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The Future of Immunity Editorial
January 1, 1997 marks a major transition in the three year gene assembly and expression, autoimmunity, toler-
ance, and lymphocyte development and activation.history of Immunity. On that day, the editorial direction
of the Journal will be transferred from Harvard/MIT in However, because the Journal is now well established,
we hope to broaden Immunity’s scope to include theBoston to Washington University School of Medicine in
St. Louis. This is a natural transition of editorship that areas of structural biology, signal transduction, cytokine
biochemistry and biology, host defense against infec-is planned to occur periodically over the lifetime of the
Journal. tious agents, and tumors and immunopathology. We
will therefore continue to support the well-representedThe outgoing editors, Abul Abbas, Frederick Alt, Lau-
rie Glimcher, and Hidde Ploegh togetherwith the reviews areas being published in the Journal, but will also ac-
tively encourage submission of high quality, state of theeditors Charles Janeway, Jr. and Al Singer have done
an outstanding job in guiding Immunity into a prominent art contributions in these other areas. We have therefore
expanded our board of associate editors to broaden theposition among immunology journals. They have been
the driving force in helping the Journal realize its stated areas of expertise represented.
Second, we are committed to maintaining the efficientmission of rapidly publishing cutting edge, peer re-
viewed papers of scientific excellence and immunologi- review of submitted papers and to publish rapidly those
that are accepted. Our intention is to preserve the cur-cal breadth. Immunity’s highly successful beginnings
are a direct result of the substantial personal commit- rent 3 week average decision time on most submitted
papers and to publish accepted papers within 8–12ments of time and effort on the part of the editors, and
the current and incoming staff of the Journal thank them weeks from submission of the final manuscript. This
short turnaround time has been intentionally establishedfor their invaluable contributions.
The new editors, Paul M. Allen, Kenneth M. Murphy, to encourage investigators to submit their most impor-
tant findings to Immunity.Robert D. Schreiber, and Emil R. Unanue, will share
equally in the editorial direction of the Journal. All have The transition process begins this month and will be
completed by January 1, 1997. All communications withhad long-standing relationships with Immunity. Two
have been associate editors since the Journal origi- the Journal will continue to be through the Cell Press
office in Cambridge, MA. All new papers submitted tonated, while the other two have been used heavily as
invited reviewers. In addition, Al Singer will stay on as Immunity after December 1 will be sent to the new edi-
tors in St. Louis. Papers that list a Washington Universitythe reviews editor, a position he has filled for the past
21 months. As a group, we look forward to the challenge faculty member as an author will be guided through the
review process by one of the past editors in Boston. Allof promoting the continued growth of Immunity and
enhancing its sphere of influence within the national and papers currently in the review process will be overseen
by the past editors until February 1, when the oversightinternational immunology community.
In order to accomplish these goals we will abide by of these papers will be transferred to St. Louis.
Thus, in sum, we approach this new challenge withthe following standards. First, we intend to maintain the
original mission of the Journal. Our goal is to publish great enthusiasm and with strong commitment. We wel-
come comments and suggestions from interested indi-high quality, novel, and exciting papers in the field of
immunology. The Journal has been successful in at- viduals and encourage them to work with us to expand
Immunity’s place within the world immunology com-tracting papers in many areas of the field, such as MHC,
antigen processing and presentation, antigen receptor munity.
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